Patent assignee · CA · COMPANY

Tekmira Pharmaceuticals Corporation

14Patents
13Active
14Granted
51Portfolio score

Filing activity: Jun 29, 2001 → Nov 20, 2013 · 8 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9345780B2 Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components Chemistry; Metallurgy 237 Active
US8642076B2 Lipid containing formulations Human Necessities 138 Active
US8802644B2 Lipid formulation Emerging Cross-Sectional Technologies 110 Active
US8883202B2 Lipid compositions Emerging Cross-Sectional Technologies 95 Active
US9051567B2 Methods for increasing efficacy of lipid formulated siRNA Chemistry; Metallurgy 92 Active
US8999351B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 91 Active
US9186325B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 89 Active
US9139554B2 Amino lipids and methods for the delivery of nucleic acids Emerging Cross-Sectional Technologies 72 Active
US7811602B2 Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof Human Necessities 64 Active
US8575123B2 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components Chemistry; Metallurgy 52 Active
US8722082B2 Lipids and compositions for the delivery of therapeutics Chemistry; Metallurgy 37 Active
US9220683B2 Lipids and compositions for the delivery of therapeutics Emerging Cross-Sectional Technologies 23 Active
US7244448B2 Liposomal antineoplastic drugs and uses thereof Human Necessities 13 Expired
US9801874B2 Method for the preparation of liposome encapsulated vincristine for therapeutic use Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.